As biotechs scale up, streamlining the planning, execution, and monitoring of outsourced clinical trials becomes critical. While CROs manage the day-to-day operations, sponsors are ultimately ...

Gueddar, Senior Director, Commercial Strategy, IQVIA Clinical Trial Financial Suite | Streamline and manage every aspect of ...

Funding advances Phase 2 expansion cohorts in pancreatic and colorectal cancer in ATM-negative patients for Artios’ potential ...

By implementing appropriate security measures, threat assessment protocols, and compliance-driven policies, healthcare ...

The shift to risk-based quality management (RBQM) in clinical trials offers market opportunities in proactive risk strategies, focusing on patient safety and data integrity. Emphasizing digital ...

To keep up with COPD research and care developments, the 2026 Global Initiative for Chronic Obstructive Lung Disease report ...

Trial management has become one of the most decisive factors in determining whether diagnostic and medtech innovations make it to market successfully. For companies developing in vitro diagnostics and ...

The CEO highlighted results from the REMAIN-1 Midpoint Cohort, where "Revita-treated patients lost an additional 2.5% of total body weight, while patients in the sham group regained about 10%, a ...

Extends cash runway into first half of 2027, beyond planned first half of 2026 proof of concept ('POC”)data readouts of SIM0505 (CDH6 ADC) and LNCB74 (B7-H4 ADC)Led by Ikarian Capital, Squadron ...

Bambusa Therapeutics, Inc. (Bambusa), a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology and inflammation (I&I), today announced the completion of ...

Q3 2025 Management View Paul Bolno, President, CEO & Director, highlighted the company's "first ever demonstration of activin E reductions in a clinical trial" with WVE-007, reporting "highly ...